Search Within

Rita Sakr

Formats
  1. Meeting Abstract (32)
  2. Journal Article (29)
Groups
  1. Surgery (52)
  2. GSK Faculty (46)
  3. Department of Pathology and Laboratory Medicine (43)
  4. Department of Medicine (28)
  5. Solid Tumor Oncology Division (28)
  6. Gynecology Disease Management Team (26)

More Groups

People
  1. Tari King (47)
  2. Jorge Reis-Filho (27)
  3. Britta Weigelt (25)
  4. Dilip Giri (23)
  5. Kiu Yan Charlotte Ng (23)
  6. Victor Andrade (21)

More People

Years
  1. 2019 (1)
  2. 2018 (2)
  3. 2017 (2)
  4. 2016 (9)
  5. 2015 (14)
  6. 2014 (4)

More Years

Publications
  1. Cancer Research (18)
  2. Journal of Clinical Oncology (7)
  3. Annals of Surgical Oncology (4)
  4. Clinical Cancer Research (4)
  5. Breast Cancer Research and Treatment (3)
  6. Modern Pathology (3)

More Publications

Publishers
  1. American Association for Cancer Research (24)
  2. American Society of Clinical Oncology (7)
  3. Springer (7)
  4. Nature Publishing Group (5)
  5. FEBS Press (3)
  6. Nature Research (3)

More Publishers

Results (61)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A mechanistic logic for dual targeting of HER2 and PI3K/AKT/mTOR signaling in HER2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Rodrik-Outmezguine, V.; Scaltriti, M. M.; Sakr, R.; Will, M.; Giri, D.; Hudis, C.; Baselga, J.; King, T.; Rosen, N.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer
    Journal Article

    Chandarlapaty, S.; Sakr, R. A.; Giri, D.; Patil, S.; Heguy, A.; Morrow, M.; Modi, S.; Norton, L.; Rosen, N.; Hudis, C.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Genomic complexity and AKT dependence in serous ovarian cancer
    Journal Article

    Hanrahan, A. J.; Schultz, N.; Westfal, M. L.; Sakr, R. A.; Giri, D. D.; Scarperi, S.; Janakiraman, M.; Olvera, N.; Stevens, E. V.; She, Q. B.; more...
    Cancer Discovery (2012)

    Fulltext@MSK | Save
  • Differentially expressed genes in window trials are influenced by the wound-healing process: Lessons learned from a pilot study with anastrozole
    Journal Article

    Morrogh, M.; Andrade, V. P.; Patil, A. J.; Qin, L. X.; Mo, Q.; Sakr, R.; Arroyo, C. D.; Brogi, E.; Morrow, M.; King, T. A.
    Journal of Surgical Research (2012)

    Fulltext@MSK | Save
  • Is there a low-grade precursor pathway in breast cancer?
    Journal Article

    King, T. A.; Sakr, R. A.; Muhsen, S.; Andrade, V. P.; Giri, D.; Van Zee, K. J.; Morrow, M.
    Annals of Surgical Oncology (2012)

    Fulltext@MSK | Save
  • Cadherin-catenin complex dissociation in lobular neoplasia of the breast
    Journal Article

    Morrogh, M.; Andrade, V. P.; Giri, D.; Sakr, R. A.; Paik, W.; Qin, L. X.; Arroyo, C. D.; Brogi, E.; Morrow, M.; King, T. A.
    Breast Cancer Research and Treatment (2012)

    Fulltext@MSK | Save
  • Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: Results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA)
    Journal Article

    Mavaddat, N.; Barrowdale, D.; Andrulis, I. L.; Domchek, S. M.; Eccles, D.; Nevanlinna, H.; Ramus, S. J.; Spurdle, A.; Robson, M.; Sherman, M.; more...
    Cancer Epidemiology Biomarkers and Prevention (2012)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer
    Meeting Abstract

    Gajria, D.; King, T. A.; Pannu, H.; Sakr, R.; Seidman, A. D.; Syldor, A.; Patil, S.; Maybody, M.; Norton, L.; Rosen, N.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Can PI3K/AKT pathway mutations predict for type of recurrence after conservative treatment for DCIS
    Meeting Abstract

    Sakr, R. A.; Andrade, V. P.; Muhsen, S.; Chandarlapaty, S.; Giri, D.; Olvera, N.; Paik, W.; Goldberg, J. I.; Van Zee, K. J.; Rosen, N.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I/II study in patients with metastatic HER2-amplified or triple-negative breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Seidman, A. D.; Modi, S.; Dickler, M.; Drullinsky, P.; Syldor, A.; Sujata, P.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save